Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Thomas M Yunger , MD

Specialist • Dayton, OH

Active NPI 1962496844 Individual Practitioner Male Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

9001 N Main St, Suite A
Dayton, OH 454151175

Call 9378320990 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

9001 N Main St
Suite A

Dayton, OH 454151175

Telephone 9378320990
Fax 9378327323
Organization at the Same NPPES Address or Phone
Rajesh C Patel Md Inc Facility NPI 1467446369

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Rajesh C Patel Md Inc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

Ohio State University College Of Medicine

Graduation Year

1995

Medicare patients

1,180 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $381,583 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $290,774 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

5,698 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$3,046,833 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $27,378.34 across 141 records.

By nature of payment (3 largest of 5)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $22,750.00 across 8 records.
  • Food and Beverage: $3,192.70 across 120 records.
  • Travel and Lodging: $1,401.05 across 10 records.

Reporting-company totals (3 largest of 17)

  • GlaxoSmithKline, LLC.: $25,545.69 across 71 records.
  • AstraZeneca Pharmaceuticals LP: $488.23 across 21 records.
  • Sanofi and Genzyme US Companies: $356.92 across 9 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

31 years (graduated 1995)

CMS Doctors and Clinicians data list 1995 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2005

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Yunger has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Yunger as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Dayton and Ohio

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 85% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: 744. Middle half: 216 to 2,030.

Too few clinicians listed under Specialist in Dayton have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 90% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: $55,907. Middle half: $22,244 to $144,453.

Too few clinicians listed under Specialist in Dayton have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 90% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: $41,063. Middle half: $16,532 to $104,577.

Too few clinicians listed under Specialist in Dayton have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 85% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: 518. Middle half: 102 to 1,924.

Too few clinicians listed under Specialist in Dayton have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Specialist in Ohio (2024, 136 clinicians with data). Median for this group: $66,137. Middle half: $1,855 to $302,101.

Too few clinicians listed under Specialist in Dayton have Medicare Part D data for 2024 to compare.

50 active clinicians are listed under Specialist with a practice address in Dayton, OH (1,313 in Ohio).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Dayton

2% of these 50 clinicians have the CMS telehealth indicator.

14% of these 50 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 141 records totaling $27,378.34.

Manufacturer Payment Nature Product Type Amount ($)
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NUCALA General $4,550.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
AREXVY General $3,900.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NUCALA General $2,600.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NUCALA General $2,600.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NUCALA General $2,600.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NUCALA General $2,600.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
NUCALA General $2,600.00
GlaxoSmithKline, LLC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TRELEGY ELLIPTA General $1,300.00
GlaxoSmithKline, LLC.
Travel and Lodging
In-kind items and services
— General $411.01
GlaxoSmithKline, LLC.
Travel and Lodging
In-kind items and services
— General $269.86
GlaxoSmithKline, LLC.
Travel and Lodging
Cash or cash equivalent
NUCALA General $245.00
GlaxoSmithKline, LLC.
Travel and Lodging
In-kind items and services
NUCALA General $235.17
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $192.55
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
— General $124.99
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $122.67
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $121.71
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $119.41
GlaxoSmithKline, LLC.
Travel and Lodging
Cash or cash equivalent
NUCALA General $113.20
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
BREZTRI General $103.90
Eli Lilly and Company
Food and Beverage
Cash or cash equivalent
ZEPBOUND General $89.98
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $84.06
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
— General $75.45
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
— General $75.45
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
FASENRA General $72.67
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
NUCALA General $71.60

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
947 506 $160.00 $124.89
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
488 327 $105.00 $88.45
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
429 205 $149.16 $117.01
94664 Evaluation of use of breathing device
254 247 $24.91 $16.81
94060 Test to measure expiratory airflow and volume changes before and after medication administration
247 244 $111.59 $36.91
94726 Test to determine lung volumes using sensors
245 243 $125.00 $52.82
94729 Test to examine how well the lungs exchange gases
245 242 $125.00 $53.17
99291 Critical care, first 30-74 minutes
170 83 $397.65 $211.27
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
156 126 $109.84 $77.87
94618 Test for exercise-induced lung stress
131 113 $55.00 $32.99
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
105 100 $297.33 $170.88
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
91 91 $240.00 $162.08
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
58 55 $75.00 $54.83
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
58 45 $210.00 $177.21
95810 Sleep study in sleep lab (6 years or older)
52 52 $410.00 $115.48
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
41 26 $50.00 $16.32
94660 Therapy procedure using a positive pressure ventilator
38 38 $120.00 $62.56
95806 Sleep study including heart rate, breathing, airflow, and effort
37 37 $150.00 $42.82
95976 Electronic analysis of neurostimulator generator with simple cranial nerve stimulator programming
35 18 $85.00 $38.78
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
35 35 $150.00 $109.06
95970 Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator
33 18 $40.00 $18.57
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older)
31 29 $200.00 $119.48
31624 Irrigation and suction of lung airways to obtain cells using an endoscope
24 23 $392.00 $70.89
99496 Transitional care management services for problem of high complexity
19 18 $325.00 $273.68
31628 Biopsy of lobe of lung using an endoscope, 1 lobe
12 11 $543.00 $63.76

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter 598 30,540 $645,244.10 160
Albuterol Sulfate Hfa Albuterol Sulfate 414 17,469 $13,168.28 177
Prednisone Prednisone 238 8,383 $1,102.54 108
Anoro Ellipta Umeclidinium Brm/Vilanterol Tr 194 10,020 $151,165.28 57
Breo Ellipta Fluticasone/Vilanterol 186 9,120 $115,272.75 39
Montelukast Sodium Montelukast Sodium 170 14,923 $1,425.33 61
Stiolto Respimat Tiotropium Br/Olodaterol Hcl 102 5,520 $85,439.42 28
Spiriva Respimat Tiotropium Bromide 91 6,420 $109,898.23 30
Azithromycin Azithromycin 88 3,421 $716.69 49
Fluticasone-Salmeterol Fluticasone Propion/Salmeterol 88 5,640 $17,039.21 35
Trazodone Hcl Trazodone Hcl 79 5,220 $599.24 23
Breztri Aerosphere Budesonide/Glycopyr/Formoterol 76 4,440 $91,687.30 29
Ofev Nintedanib Esylate 68 2,040 $748,302.86 —
Roflumilast Roflumilast 62 4,036 $8,274.10 23
Clonazepam Clonazepam 54 2,171 $491.13 16
Furosemide Furosemide 51 3,069 $176.77 20
Eliquis Apixaban 45 1,620 $31,590.97 —
Fluticasone Propionate Fluticasone Propionate 41 2,790 $407.19 15
Omeprazole Omeprazole 35 2,550 $374.43 13
Gabapentin Gabapentin 34 2,670 $395.35 13
Levofloxacin Levofloxacin 30 276 $133.60 24
Doxycycline Hyclate Doxycycline Hyclate 28 206 $150.11 22
Combivent Respimat Ipratropium/Albuterol Sulfate 23 1,065 $20,243.64 —
Wixela Inhub Fluticasone Propion/Salmeterol 23 1,290 $6,331.09 —
Levalbuterol Tartrate Hfa Levalbuterol Tartrate 21 585 $1,333.78 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Specialist Primary Specialty

NUCC Taxonomy Code: 174400000X

License # reported to NPPES OH OH 35-07-1174Y

An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: State Medical Board of Ohio.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
2092891 (OH)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - PULMONARY DISEASE

Medicare Enrollment ID

I20080726000142

Enrollment State Jurisdiction

OH

PECOS Control ID

3173696929

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Rajesh C Patel Md Inc

9001 N Main St, Dayton, OH 454151154

Phone: 9378320990

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

7 listed
Dr. Patrick Allan , MD

Internal Medicine - Pulmonary Disease

NPI 1609954940

Doctor of Medicine (M.D.)

Nicole Epard , CNP

Nurse Practitioner - Acute Care

NPI 1619534781

Certified Nurse Practitioner

Dr. Anuj Goyal , MD

Internal Medicine - Pulmonary Disease

NPI 1144214818

Doctor of Medicine (M.D.)

Dr. Timothy Hwalek , DO

Internal Medicine - Pulmonary Disease

NPI 1568880904

Doctor of Osteopathic Medicine (D.O.)

NPI 1801880851

Doctor of Medicine (M.D.)

NPI 1225022965

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated September 07, 2005.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1962496844
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: September 07, 2005
Last Update: February 10, 2011
Sole Proprietor: No

Other Specialists in Dayton

All Specialists in Dayton

Mailing Address

9001 N Main St, Suite A

Dayton, OH 454151175

Phone: 9378320990

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.